Sather Loads Up Paycom With 18,000 Shares Bought Last Quarter

Sather Financial disclosed in a Jan 26, 2026 SEC filing that it bought 18,035 shares of Paycom (NYSE:PAYC) in Q4—an estimated $3.20M at the quarter’s average price—yet the position’s value fell $9.32M to $42.71M at quarter-end, representing 2.3% of the fund’s $1.86B reportable U.S. equity AUM. Paycom traded at $152.29 on Jan 23, 2026 (market cap $8.57B) with TTM revenue of $2.00B and net income of $453.2M; the stock is down ~25% year-over-year and >60% over five years and now trades at an approximate P/E of 19, indicating a value-oriented accumulation amid slowing growth.

Analysis

Market structure: Sather’s modest buy (18,035 shares; position = 268k shares, $42.7M) is signal not supply shock — it highlights value hunting in a beaten-down HCM name (PAYC -25% YoY; -60% 5y). Winners: value/momentum buyers and potential acquirers hunting scale in SMB payroll; losers: high-multiple HCM incumbents if pricing competition intensifies. Cross-asset: limited bond/FX impact; equity options skew for PAYC will stay elevated near earnings, raising implied vols 20–40% vs. SPX.

Risk assessment: Tail risks include data/privacy regulation or a major payroll outage (customer churn spike); macro downturn could cut SMB hiring and ARR growth below current ~10% run-rate. Immediate (days): event-driven volatility around earnings/earnout headlines; short-term (1–3 quarters): guidance/renewal trends decide direction; long-term (12–36 months): re-rating if ARR growth re-accelerates above ~15% or margins expand. Hidden dependency: outsized sensitivity to SMB hiring cycle and single-tenant payroll reliability.

Trade implications: Direct play — accumulate PAYC under $150 in tranches to build a 2–3% portfolio position, stop-loss 20% below cost, target 40–50% upside over 12–24 months if growth normalizes to ~15% and P/E re-rates to mid-20s. Pair trade — long PAYC vs short ADP (or PAYX) sized 0.5–1% to hedge macro SMB risk; expect relative outperformance if Paycom regains product-led share. Options — buy Jan 2027 $160 LEAP calls (or nearest OTM) and sell 3–6 month calls to reduce carry if you expect 12+ month recovery.

Contrarian angles: Consensus treats deceleration as permanent; market may be over-discounting secular upside from automation/upsell. Historical parallel: Workday/ADP cycles where initial decel priced-in then reversed with product upgrades and enterprise push. Watch for unintended consequence — aggressive price cuts by incumbents could compress gross margins by 200–400bps; monitor churn and deal sizes for early signs.

Key Decisions for Investors

• Establish a phased long position in PAYC (ticker PAYC) equal to 2–3% of portfolio if average entry price < $150; tranche in 25%/25%/50% and place a hard stop-loss at 20% below weighted cost. Target 40–50% upside over 12–24 months if revenue growth re-accelerates to ~15% and P/E expands to mid-20s.
• Implement a relative-value pair: long PAYC vs short ADP (or PAYX) sized 1:1 worth 0.5–1% of portfolio to isolate company-specific execution risk from SMB macro risk; close within 6–12 months or on divergence >15%.
• Buy Jan 2027 LEAP calls on PAYC (nearest $160 strike or 10% OTM) sized to 30–50% of the intended equity exposure and sell 3–6 month calls to finance carry if IV is elevated; reassess after next two quarterly reports.
• Monitor specific operational metrics over the next 60 days: if quarterly net new ARR growth <5% QoQ OR customer churn rises >1ppt QoQ OR FY26 guidance implies revenue growth <8%, reduce PAYC exposure by at least 50%.